Control in the Hospital by Extensive Clinical rules for Unplanned hospitalisations in elderly Patients.
- Conditions
- medication safetyreadmissionclinical rulesmedication reviewCDSS
- Registration Number
- NL-OMON21393
- Lead Sponsor
- Gerontopharmacology, Zuyderland Medical Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 2400
The study population consists of older people admitted unplanned to the hospital and fulfilling the following criteria: 1) aged 60 years and over, 2) ability to give informed consent, 3) polypharmacy (> 5 drugs chronically), 4) at least two signals from the trigger list as proposed by the report Eindrapport medicatieveiligheid.
The intention of the study is to include the normal population offered to the hospital as much as possible. However, due to legal constraints and to avoid certain biases potential subjects who meets any of the following criteria will be excluded from participation in this study: intentional intoxications, patients treated with cytostatics, patients with a life expectancy of less than 3 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is the number of readmissions during the year after admission. An economic evaluation and quality of life analysis is part of the proposal.
- Secondary Outcome Measures
Name Time Method Secondary endpoints of this study are; number of emergency department contacts, number of nursing home admissions during the year after patients’ inclusion in the study, death, time to hospital readmission, the number of hospital readmissions during the following 30, 180 and 365 days, the number of medication-related hospital (re) admissions, the combined endpoint hospital readmissions, emergency department contacts, nursing home admissions or death, total costs (from a societal perspective) and the Quality Adjusted Life Years (QALY) score.